» Articles » PMID: 21167233

Sustained Repression and Translocation of Ntcp and Expression of Mrp4 for Cholestasis After Rat 90% Partial Hepatectomy

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2010 Dec 21
PMID 21167233
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: To clarify the mechanism of persistent cholestasis after massive hepatectomy, the relationship between such cholestasis and the expression and localization of organic anion transporters for bile acids was examined in a rat model.

Methods: Male Sprague-Dawley rats were subjected to 90% hepatectomy, and tissues were harvested at 0, 1, 3, and 7 days for microarray analysis, quantitative real-time polymerase chain reaction (RT-PCR), Western blotting, and immunohistochemistry to examine the expression of multidrug resistance protein 4 (Mrp4), bile salt export pump (Bsep), and sodium-dependent taurocholate cotransporting polypeptide (Ntcp).

Results: Persistently elevated levels of serum bile acids were observed at days 3 and 7. RT-PCR and Western blotting indicated that the expression of Mrp4, a bile acid export pump located in the basolateral membrane, was increased at day 3. The expression of Ntcp, a transporter used to uptake bile acids from the sinusoids, was significantly decreased throughout the period. The levels of Bsep, an export pump localized to the canalicular membrane, were unchanged. Immunohistochemistry revealed the localization of Mrp4 and Bsep in the basolateral and canalicular membranes, respectively. On the other hand, at days 3 and 7, Ntcp was localized in the cytoplasm and was hardly detected in the basolateral membrane.

Conclusions: These results suggested that the sustained repression and translocation of Ntcp and the expression of Mrp4 at the basolateral membrane seem to be responsible for the high blood bile acids levels after massive hepatectomy.

Citing Articles

Labetalol and soluble endoglin aggravate bile acid retention in mice with ethinylestradiol-induced cholestasis.

Igreja Sa I, Tripska K, Faradonbeh F, Hroch M, Lastuvkova H, Schreiberova J Front Pharmacol. 2023; 14:1116422.

PMID: 36778021 PMC: 9909014. DOI: 10.3389/fphar.2023.1116422.


Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.

Di Ciaula A, Bonfrate L, Baj J, Khalil M, Garruti G, Stellaard F Nutrients. 2022; 14(23).

PMID: 36500979 PMC: 9738051. DOI: 10.3390/nu14234950.


Mesenchymal stem cells ameliorate lipid metabolism through reducing mitochondrial damage of hepatocytes in the treatment of post-hepatectomy liver failure.

Wang J, Ding H, Pan C, Shi X, Ren H Cell Death Dis. 2021; 12(1):111.

PMID: 33479191 PMC: 7820227. DOI: 10.1038/s41419-020-03374-0.


Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Portincasa P, Di Ciaula A, Garruti G, Vacca M, De Angelis M, Wang D Nutrients. 2020; 12(12).

PMID: 33266235 PMC: 7760347. DOI: 10.3390/nu12123709.


Lack of Multidrug Resistance-associated Protein 4 Prolongs Partial Hepatectomy-induced Hepatic Steatosis.

Donepudi A, Smith G, Aladelokun O, Lee Y, Toro S, Pfohl M Toxicol Sci. 2020; 175(2):301-311.

PMID: 32142150 PMC: 7850122. DOI: 10.1093/toxsci/kfaa032.